Browse > Article
http://dx.doi.org/10.5720/kjcn.2012.17.3.341

Cost-benefit Analysis of Sodium Intake Reduction Policy in Korea  

Lee, Chul-Hee (Department of Economics, Seoul National University)
Kim, Dae-il (Department of Economics, Seoul National University)
Hong, Jeong-Lim (Department of Economics, Seoul National University)
Koh, Eun-Mi (Department of Health Industry & Policy, Korea Health Industry Development Institute)
Kang, Baeg-Won (Nutrition Policy Office, Korea Food & Drug Administration)
Kim, Jong-Wook (Nutrition Policy Office, Korea Food & Drug Administration)
Park, Hye-Kyung (Nutrition Policy Office, Korea Food & Drug Administration)
Kim, Cho-Il (Department of Health Industry & Policy, Korea Health Industry Development Institute)
Publication Information
Korean Journal of Community Nutrition / v.17, no.3, 2012 , pp. 341-352 More about this Journal
Abstract
It is well established that excessive sodium intake is related to a higher incidence of chronic diseases such as hypertension, stroke, coronary heart disease, cardiovascular disease and gastric cancer. Although the upper limit of the current sodium intake guideline by WHO is set at 2,000 mg/day for adults, sodium intake of Koreans is well over 4,700 mg/capita/day implying an urgent need to develop and implement sodium intake reduction policy at the national level. This study investigated the cost-effectiveness of the sodium intake reduction policy, for the first time, in Korea. Analyses were performed using most recent and representative data on national health insurance statistics, healthcare utilization, employment information, disease morbidity/mortality, etc. The socioeconomic benefits of the policy, resulting from reduced morbidity of those relevant diseases, included lower medical expenditures, transportation costs, caregiver cost for inpatients and income losses. The socioeconomic benefits from diminished mortality included reductions in earning losses and welfare losses caused by early deaths. It is estimated that the amount of total benefits of reducing sodium intake from 4.7 g to 3.0 g is 12.6 trillion Korean Won; and the size of its cost is 149 billion Won. Assuming that the effect of sodium intake reduction would become gradually evident over a 5-year period, the implied rate of average return to the sodium reduction policy is 7,790% for the following 25 years, suggesting a very high cost-effectiveness. Accordingly, development and implementation of a mid-to-long term plan for a consistent sodium intake reduction policy is extremely beneficial and well warranted.
Keywords
sodium intake reduction; health; cost-benefit analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 National Health Insurance Corporation/Health Insurance Review & Assessment Service (2010): 2009 National Health Insurance Statistical Yearbook. Available from http://www.nhic.or.kr [cited 2011 February 10]
2 National Health Insurance Corporation/Health Insurance Policy Research Institute (2010): 2009 Survey on medical expenditure of patients insured by National Health Insurance. Available from http://www.nhic.or.kr [cited 2011 March 10]
3 Rhee M-Y, Yang SJ, Oh SW, Park Y, Kim C-i, Park H-K, Park SW, Park C-Y (2011): Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res 34(5): 606-611
4 Rosen S (1986): The theory of equalizing differences. in orley ashenfelter and richard layard (eds.) Handbook of Labor Economics, Volume 1, New York NY: North-Holland, pp. 641- 692s
5 Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larsen HK, Meyer HE, Bønaa KH, Thelle DS (2000): Cost and health consequences of reducing population intake of salt. J Epidemiol Community Health 54(9): 697-702
6 Stamler J (1997): The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 65(2S): 626-642
7 Stamler R (1991): Implications of the INTERSALT study. Hypertension 17(S1): 116-120
8 Statistics Korea (2010): 2009 Economically Active Population Survey. Available from http://kosis.go.kr [cited 2011 May 15]
9 Statistics Korea (2011): Annual Report on the Cause of Death Statistics (2010). Available from http://kostat.go.kr [cited 2011 February 16]
10 Strazzullo P, D'Elia L, Kandala N-B, Cappuccio F (2009): Salt intake, stroke, and cardiovascular disease: meta-anlaysis of prospective studies. Br Med J 339: b4567
11 Tsugane S, Sasazuki S, Kobayashi M, Sasaki S (2004): Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 90(1): 128-134
12 Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A (2001): Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 357(9259): 848-851
13 World Health Organization (2003): Diet, nutrition and the prevention of chronic diseases. ort of a joint WHO/FAO Expert Consultation. Geneva, World Health Organization (WHO Technical report series, No. 916)
14 World Health Organization (2010a): Creating an enabling environment for population-based salt reduction strategies. Report of a joint technical meeting held by WHO and the Food Standards Agency, United Kingdom, July 2010
15 World Health Organization (2010b): International statistical classification of diseases and related health problems, 10th Revision. ICD-10 Version:2010. Available from http://apps.who.int/classifications/icd10/browse/2010/en [cited 2011 March 10]
16 World Health Organization (2011): Call for public comments on the scoping of sodium and potassium recommendations. Available from http://www.who.int/nutrition/events/NUGAG_dietandhealth_ subgroup_ call_public_comment_scope_of_Na_K.pdf [cited 2011 February 10]
17 World Health Organization (2012): Call for public comments - Draft WHO Guidelines sodium and potassium. Available from http:// www.who.int/nutrition [cited 2012 February 3]
18 Ahn BC, Joung H (2005): Socioeconomic cost of obesity in Korea. Korean J Nutr 38(9): 786-792
19 Blaustein MP, Hamlyn JM (1991): Pathogenesis of essential hypertension : a link between dietary salt and high blood pressure. Hypertension 18(5S): 184-195
20 Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB (2000): Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13(3): 169-177
21 Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M (1996): Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. Br Med J 312(7041): 1249-1253
22 Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH (2005): Cost-effectiveness analysis of hypertension guidelines in South Africa. Circ 112: 3569-3576
23 Gibson J, Stillman S, Mckenzie D, Rohorua H (2010): Natural experiment evidence on the effect of migration on blood pressure and hypertension. IZA Discussion Paper No. 5232
24 INTERSALT Cooperative Research Group (1988): INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J 297(6644): 319-328
25 He FJ, MacGregor GA (2004): Effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews. 2004(3): CD004937
26 He FJ, MacGregor GA (2008): A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 23(6): 363-384
27 He J, Oqden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK (1999): Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. J Am Med Assoc 282(21): 2027-2034
28 Joffres MR, Campbell NR, Manns B, Tu K (2007): Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol 23(6): 437-443
29 Jung YH, Ko SJ (2004): Estimating socioeconomic cost of five major diseases. Korean J Public Finance 18(2): 77-104
30 Jung YH, Ko SJ (2006): The socioeconomic cost of diseases in Korea. J Prev Med Public Health 39(6): 499-504
31 Korea Employment Information Service (2010): 2009 Occupational employment statistics. Available from http://survey.keis.or.kr [cited 2011 May 20]
32 Korea Food & Drug Administration (2011): Sodium reduction initiative - promoters' meeting. Press Release 26/12/2011
33 Korea Food & Drug Administration/Korea Health Industry Development Institute (2012): Cost-benefit analysis of sodium intake reduction policy and international collaboration with WHO for establishing sodium intake guidelines
34 Korean Nutrition Society (2010): Dietary reference intakes for Koreans. 1st revision Hanareum, Seoul, pp.367-381
35 Ministry of Health and Welfare/Korea Centers for Disease Control & Prevention (2008): Korea Health Statistics 2007: Korea National Health and Nutrition Examination Survey (KNHANES IV-1) 2007
36 Lee C (2011): In-utero exposure to the Korean war and its long-term effects on health and economic outcomes. 2012 ASSA Meetings
37 Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA (2005): Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85(2): 679-715
38 Ministry of Employment and Labor (2010): Report on 2009 Wage Structure Survey. Available from http://www.moel.go.kr [cited 2011 May 20]
39 Ministry of Health and Welfare/Korea Centers for Disease Control & Prevention (2009): Korea Health Statistics 2008: Korea National Health and Nutrition Examination Survey (KNHANES IV-2) 2008
40 Ministry of Health and Welfare/Korea Centers for Disease Control & Prevention (2010): Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey (KNHANES IV-3) 2009
41 Ministry of Health and Welfare/Korea Centers for Disease Control & Prevention (2011): Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1) 2010
42 Ministry of Health and Welfare/Korea Institute of Health and Social Affairs (2006): The third Korea National Health & Nutrition Examination Survey (KNHANES III), 2005 - Health Interview Survey
43 Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, Lawes CMM, Evans DB (2003): Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361(9359): 717-725
44 National Health Insurance Corporation/Health Insurance Review & Assessment Service (2009): 2008 National Health Insurance Statistical Yearbook. Available from http://www.nhic.or.kr [cited 2011 March 10]